Get more info on this report!Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Ind...
o   Varicella                    o   Other Pediatric                Adult Vaccines:                  o Cervical Cancer    ...
The Global Vaccine Industry        o Scope and Methodology        o Overview        o Pediatric Preventative Vaccines     ...
o  Hepatitis A       o  Measles, Mumps and Rubella       o  Measles       o  Mumps       o  Rubella       o  Meningococcal...
o   Diphtheria-Tetanus        o   Hepatitis                Hepatitis A                Hepatitis B        o Influenza    ...
The Vaccine Safety Datalink Project    Phase IV studies    The Vaccine Injury Compensation Program    Countermeasures Inju...
o   Strategic Alliances   o   Vaccine Products   o   Financial InformationBaxter Healthcare   o History and Lines of Busin...
o   Vaccine Products        o   Financial Information     Novartis         o History and Lines of Business         o Strat...
India, China, Rest of World) 2005-2014 Revenues (in millions)     Table 3-8: World Pediatric Hepatitis Vaccine Market 2005...
Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines      Available immediately for Online Download a...
Upcoming SlideShare
Loading in …5
×

Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

1,664 views
1,606 views

Published on

Published in: Health & Medicine, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,664
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
21
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry

  1. 1. Get more info on this report!Vaccines 2010: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing IndustryAugust 1, 2010Vaccines have been one of the faster growing areas of the pharmaceutical industry, andduring a troubling series of years, they have been the superstars of many companiesportfolios. Theyve also attracted the attention of insurance companies, retail outlets andthe media. The global market for vaccines experienced strong growth through 2009 andthis is expected to continue through the forecast period. Growth is being fueled by newproduct introductions and rising usage in all regions.Kalorama Information has been closely following vaccine markets and since 2006 hasinstituted a yearly market research report schedule to keep up with fast-movingdevelopments. Our latest comprehensive update, Vaccines 2010: World MarketAnalysis, Key Players, and Critical Trends in a Fast-Changing Industry, examines themarket for vaccines used in humans for various disease. This state-of-the-industryreport is a must-have for any executive who wants to stay on top of a rapidly changingmarket and see what’s expected down the road. You can count on the objectivity andaccuracy of our numbers and analysis—whether youre preparing a strategicpresentation, benchmarking your companys performance against the competition,preparing a new product launch or seeking out an acquisition or a new partnership.The report covers only commercialized vaccines and developmental vaccines fordiseases that are already vaccine-preventable; it does not cover emerging vaccines fordiseases that are not currently vaccine-preventable.Included in this report are current market size and forecast for the following vaccines: Pediatric Vaccines: o Combinations o Hepatitis o HIB o MMR o Pneumococcal o Poliovirus
  2. 2. o Varicella o Other Pediatric Adult Vaccines: o Cervical Cancer o Hepatitis o Influenza o Pneumococcal o Travel; DT; Misc. Important trends such as vaccine safety, vaccine shortages, preventing pandemics, vaccines and bioterrorism, DNA vaccination, innovations in vaccine delivery systems and innovations in vaccine Production are covered in the report. In addition, the reort profiles key competitors in the vaccine industry. Companies profiled in the report include: AlphaVax, Inc. Bavarian Nordic A/S Baxter Healthcare Bharat Biotech Celldex Therapeutics Crucell Emergent biosolutions GlaxoSmithKline Medimmune Merck & Co. Inc Nabi Biopharmaceuticals Novartis Pfizer Sanofi Pasteur Sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for the historic 2005 to 2009 period and forecasts are provided through 2014. Historical information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives and other experts were conducted to capture the perspectives from industry participants’ point of view and assess trends, and form the basis of the forecasting and competitive analysis. Table of ContentsCHAPTER ONE: EXECUTIVE SUMMARY
  3. 3. The Global Vaccine Industry o Scope and Methodology o Overview o Pediatric Preventative Vaccines The Market Adult Preventative Vaccines The Market Total Market Issues and TrendsCHAPTER TWO: INTRODUCTION TO VACCINES A Brief History: The Development of Vaccines The Immune Response Mechanism of Action Types of Vaccines o Attenuated (Weakened) Live Viruses o Killed (Inactivated) Viruses o Toxoid Vaccines o Genetically Engineered/Modified Vaccines o Subunit Vaccines o Conjugate Vaccines o DNA Vaccination Vaccine Approval ProcessCHAPTER THREE: PEDIATRIC PREVENTIVE VACCINES Introduction Childhood Immunization in the United States o Childhood Immunization Rates o Challenges to the Vaccine Delivery System o The Effect of U.S. Health Care Reform o Recommended Childhood Immunization Schedule o State Immunization Recommendations o United Nations Initiatives Pediatric Vaccine Products o BCG o Diphtheria, Tetanus, Pertussis, Hepatitis B and Polio o Diphtheria o Pertussis o Tetanus o Hepatitis B o Poliomyelitis o Haemophilus Influenzae Type B
  4. 4. o Hepatitis A o Measles, Mumps and Rubella o Measles o Mumps o Rubella o Meningococcal Disease o Pneumococcal Conjugate o Rotavirus o Varicella Pediatric Vaccines in Development Cost of Vaccines in the United States The World Market for Pediatric Preventive Vaccines o Total Market Size and Forecast o Hepatitis Vaccine Market  Market Analysis  Leading Products and Competitors o Haemophilus Influenzae Type B Vaccine Market  Market Analysis  Leading Products and Competitors o Measles, Mumps and Rubella Vaccines  Market Analysis o Combination Vaccines Market  Market Analysis  Leading Products and Competitors o Pneumococcal Vaccine  Leading Products and Competitors o Poliovirus Vaccine  Market Analysi  Leading Products and Competitors o Varicella Vaccine  Market Analysis  Leading Products and Competitors o Other Vaccines Market  Market Analysis  Leading Products and CompetitorsCHAPTER FOUR: ADULT PREVENTIVE VACCINES Introduction Adult Vaccine-Preventable Diseases: Facts and Figures Global Influenza Surveillance Program Recommendations for Adult Immunizations o WHO International Health Regulations Adult Vaccine Products o BCG o Cervical Cancer o Cholera
  5. 5. o Diphtheria-Tetanus o Hepatitis  Hepatitis A  Hepatitis B o Influenza o Japanese Encephalitis o Pneumococcal Disease o Rabies o Shingles o Typhoid Fever o Yellow Fever Adult Vaccines in Development Total Market Size and Forecast o Cervical Cancer Market o Market Analysis o Leading Products and Competitors o Hepatitis Market o Market Analysis o Leading Products and Competitors o Influenza Vaccine Market o Market Analysis o Leading Products and Competitors o Market Analysis o Leading Products and Competitors o Travel, DT, and Miscellaneous Vaccine Market o Market Analysis o Leading Products and CompetitorsCHAPTER FIVE: VACCINES MARKET SUMMARY Trends Driving the Vaccines Market Market Size and Forecast Vaccine Sales by Region Vaccine Market Competitors Pediatric Vaccines Major Manufacturer’s Market Share Adult Vaccines Major Manufacturer’s Market ShareCHAPTER SIX: ISSUES AND TRENDS Vaccine Safety Refusal to Immunize Obesity Post-Licensure Surveillance Vaccine Adverse Event Reporting System
  6. 6. The Vaccine Safety Datalink Project Phase IV studies The Vaccine Injury Compensation Program Countermeasures Injury Compensation Program World Health Organization Other Initiatives The Future of Vaccine Safety o Vaccine Shortages o Preventing Shortages in the Developed Countries o Financial incentives o Equitable pricing o Vaccine stockpiles o Preventing Shortages in Developing Nations o Vaccine bonds o Preventing Pandemics o U.S. National Vaccine Plan Vaccines and Bioterrorism Overview Project Bioshield Act National Bio and Agro-Defense Facility Vaccine Treatment and Evaluation Units Anthrax Smallpox Tularemia Viral Hemorrhagic Fevers DNA Vaccination Innovations in Vaccine Delivery Systems o Edible Vaccines o Mucosal Delivery o Intranasal Delivery o Vaccine Patches o Vaccine Chips Innovations in Vaccine Production o Tobacco Plants o Insects o Nanoparticle SystemsCHAPTER SEVEN: COMPANY PROFILES AlphaVax, Inc. o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial Information Bavarian Nordic A/S o History and Lines of Business
  7. 7. o Strategic Alliances o Vaccine Products o Financial InformationBaxter Healthcare o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationBharat Biotech o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationCelldex Therapeutics o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationCrucell o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationEmergent Biosolutions o History and Lines of Business o Strategic Acquisition and Alliance o Vaccine Products o FinancialGlaxoSmithKline o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationMedimmune o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationMerck & Co. Inc o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationNabi Biopharmaceuticals o History and Lines of Business o Strategic Alliance
  8. 8. o Vaccine Products o Financial Information Novartis o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial Information Pfizer o History and Lines of Business o Strategic alliances o Vaccine Products o Financial Information Sanofi Pasteur o History and Lines of Business o Strategic Alliances o Vaccine Products o Financial InformationAPPENDIX: COMPANY DIRECTORYLIST OF EXHIBITSCHAPTER ONE: EXECUTIVE SUMMARY Figure 1-1: World Market for Pediatric Vaccines 2005-2014 Revenues (in millions) Figure 1-2: World Market for Adult Vaccines 2005-2014 Revenues (in millions)CHAPTER TWO: INTRODUCTION TO VACCINES Table 2-1: Impact of Vaccines in the 20th Century Annual Morbidity in the 20th Century vs 2009 Table 2-2: Vaccine-Preventable Diseases, June 2010 Table 2-3: VAERS Table of Reportable Events Following VaccinationCHAPTER THREE PEDIATRIC PREVENTIVE VACCINES Table 3-1: Global Immunization Rates by Vaccine Type 2008 Table 3-2: Immunization Profile of the United States: Population by Age Group, Number of Vaccine- Preventable Diseases Reported by Disease 2002-2008 Table 3-3 : U.S. Recommended Immunization Schedule for Children Ages 0 Through 6 Years, 2010 Table 3-4: U.S. Recommended Immunization Schedule for Adolescents Ages 7 to 18 Years, 2010 Table 3-5: Selected Pediatric Vaccines in Development, June 2010 Table 3-6 : World Market for Pediatric Vaccines by Type (DTaP/DTP, Hep, HiB, MMR, Combinations, Pneumococcal, Polio, Varicella, Others) 2005-2014 Revenues (in millions) Figure 3-1: Market Share of Pediatric Vaccines by Type 2009 Figure 3-2: Market Share of Pediatric Vaccines, by Type 2014 Table 3-7 : World Market for Pediatric Vaccines by Region (U.S., North America, South America, EU, Japan,
  9. 9. India, China, Rest of World) 2005-2014 Revenues (in millions) Table 3-8: World Pediatric Hepatitis Vaccine Market 2005-2014 World Hib Vaccine Market, 2005-2014 Table 3-10: World MMR Vaccines Market 2005-2014 Table 3-11 World Combination Vaccines Market 2005-2014 Table 3-12 World Pediatric Pneumococcal Vaccine Market 2005-2014 Table 3-13 World Poliovirus Vaccine Market 2005-2014 Table 3-14 World Varicella Vaccine Market 2005-2014 Table 3-15 World Pediatric Other Vaccines Market 2005-2014CHAPTER FOUR ADULT PREVENTIVE VACCINES Table 4-1 Universal Adult Immunization Schedule 2010 Table 4-2 Adult Immunization Schedule for Populations with Special Medical Conditions, 2010 Table 4-3 Initiatives to Require HPV Vaccination by U.S. State, 2010 Table 4-4 WHO Pandemic Classification Schedule Selected Adult Preventive Vaccines in Development, 2010 Table 4-6 World Market for Adult Preventive Vaccines by Type (Hepatitis, Influenza, Pneumococcal, Travel/DT/Misc.), 2005-2014 Revenues (in millions) Figure 4-1 Market Share of Adult Vaccines, by Type, 2009 Figure 4-2 Market Share of Adult Vaccines, by Type, 2014 Table 4-7 World Market for Adult Vaccines by Region (U.S., North America, South America, EU, Japan, India, China, Rest of World) 2005-2014 Revenues (in millions) Table 4-8 World Cervical CancerVaccine Market 2005-2014 Table 4-9 World Hepatitis Vaccine Market 2005-2014 World Influenza Vaccine Market 2005-2014 Table 4-11 CDC Goal to Double Flu Immunization by 2010 Group and Estimated Immunization Rate (2000 vs 2010) Table 4-12 2009 Estimated Population by Region and Selected Age Group (in millions) Table 4-13 World Pneumococcal Vaccine Market 2005-2014 World Travel; Diphtheria-Tetanus; Miscellaneous Vaccines Market 2005-2014 160CHAPTER FIVE VACCINES MARKET SUMMARY Figure 5-1 Sales Growth of Vaccines vs. Pharmaceuticals 2005-2014 Figure 5-2 World Market for Vaccines by Type 2005-2014 Table 5-1 The World Vaccines Market by Vaccine Type 2005-2014 Revenues (in millions Figure 5-3 World Market for Vaccines Share by Type, 2005, 2009 and 2014 Table 5-2 The World Vaccines Market by Region 2005-2014 Revenues (in millions) Table 5-3 Major Manufacturers’ Shares of the World Vaccine Market, 2009 Figure 5-3 2009 World Vaccines Market Share, by Leading Competitors Table 5-4 Major Manufacturer’s Shares of the World Pediatric Vaccine Market 2009 Figure 5-5 Market Share of Pediatric Vaccines Market, 2009 Table 5-5 Major Manufacturer’s Shares of the World Adult Vaccine Market 2009 Figure 5-6: Market Share of Adult Vaccines Market 2009CHAPTER SIX ISSUES AND TRENDS
  10. 10. Table 6-1: Selected Companies/Laboratories Developing Biodefense Vaccines Available immediately for Online Download at http://www.marketresearch.com/product/display.asp?productid=2684026 US: 800.298.5699 UK +44.207.256.3920 Intl: +1.240.747.3093 Fax: 240.747.3004

×